Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Oleg Butovsky, Ph.D.

Title
Institution
Department
Address
Phone
Profile Picture

Biography
Tel Aviv University, IsraelB.Sc. cum laude09/1995Biology Science
The Weizmann Institute of Science, IsraelM.Sc. magna cum laude09/2000Neurobiology Science
The Weizmann Institute of Science, IsraelPh.D. summa cum laude09/2005Neuroimmunology
BWH/Harvard Medical School, USAPostdoctoral Training2012Center for Neurologic Diseases
BWH/Harvard Medical School, USAInstructor in Neurology2014Center for Neurologic Diseases
BWH/Harvard Medical School, USAAssistant Professor2018Center for Neurologic Diseases
BWH/Harvard Medical School, USAAssociate ProfessorPresentCenter for Neurologic Diseases
2012
Translational Research Advancing Therapies for ALS award
2014
The Race to Erase MS – Faculty Award
2016
Commitment to Innovation Discovery
Updated Awards: https://orcid.org/0000-0003-0186-8867

Overview
My laboratory focuses on basic fundamental questions of microglia biology and developing novel microglia-targeting therapies. One of the important new areas in neuroimmunology is the emerging field of the innate immune system and the interface between microglia and the peripheral innate immune system. Our novel tools and therapeutic approaches are applicable to neurological diseases including Multiple sclerosis, Amyotrophic lateral sclerosis and Alzheimer’s disease that currently lack therapy.

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R21NS104609 (BUTOVSKY, OLEG) Jul 1, 2018 - Jun 30, 2020
    NIH/NINDS
    Identification of exosome signature in serum from ALS patients
    Role: Principal Investigator
  2. A222469 (Butovsky, Oleg) Apr 1, 2018 - Mar 1, 2019
    Genzyme
    Evaluate the effect of CFMS antagonist on microglia cell phenotypes and gene signatures
    Role Description: The goal of this project is to determine the contribution of CSF1R in microglia modulation of functional properties during processes of tissue injury, neuroinflammation and neurodegeneration.
    Role: Principal Investigator
  3. R01EY027921 (WEINER, HOWARD L) Sep 30, 2017 - Jun 30, 2020
    NIH/NEI
    Role of Microglia in Retinitis Pigementosa
    Role Description: NIH R01EY027921 (PI:Weiner/Co-PI: Butovsky) Role: Co-PI. The focus of this grant proposal is to characterize retinal microglia and how they regulate and/or participate in retinal damage in both animal models of retinitis pigmentosa and in eyes from human subjects. We will investigate whether retinitis pigmentosa in animal models can be treated by specifically targeting and modulating microglia. We will use new technology and approaches to understand features of microglia cells that can then be exploited to develop novel microglia-targeting therapies to treat humans with retinitis pigmentosa.
    Role: Principal Investigator
  4. R01AG054672 (BUTOVSKY, OLEG) Aug 15, 2017 - Apr 30, 2022
    NIH/NIA
    Targeting the miR-155 and APOE-TREM2 pathways to restore dysfunctional microglia in Alzheimer?s disease
    Role Description: Targeting the miR-155 and APOE-TREM2 pathways to restore dysfunctional microglia in Alzheimer’s disease NIH/NIA R01 AG054672-01 (Butovsky) Role: PI. We hypothesize that danger signals (dead neurons and amyloid-ß peptides) alter functional phenotype of innate immune cells from the homeostatic (M0) to newly discovered neurodegenerative (MGnD) phenotype. We will address our hypothesis in the following aims: 1) targeting Trem2-induced Apoe/miR155 pathway to restore M0-homeostatic microglia in AD mouse models. We will specifically delete miR-155, Apoe and Trem2 in microglia of AD mouse models; 2) restoration of M0-homeostatic microglia via Mertk pathway in humanized APOE4 and AD mice. We will specifically over-express Mertk in microglia of APOE4 humanized mice and AD mouse models. We will validate our findings by investigating AD brains from prodromal to advanced stages. The goal of our investigations is to define new molecular mechanisms of immune and inflammatory processes that contribute to the development and progression of AD, which in turn will provide a basis for new approaches for immune based therapy of the disease.
    Role: Principal Investigator
  5. APOE:Butovsky (Butovsky, Oleg) Jul 1, 2017 - Jun 1, 2019
    Cure Alzheimer’s Fund
    The role of APOE in microglia regulation in neurodegeneration
    Role Description: We hypothesize that danger signals (dead neurons, dystrophic axons and amyloid-ß peptides) induce APOE signaling, which alters functional phenotype of microglia from the homeostatic (M0) to neurodegenerative MGnD) phenotype in a gender-dependent manner. We will address the hypothesis in the following aims: 1) determine the role of human APOE isoforms in microglia regulation in a gender-dependent manner in aging and mouse models of neurodegeneration (Holtzman/Greengard collaboration); 2) investigate how APOE isoforms affect phenotype and function of recruited human inflammatory monocytes (Bu/Wellington collaboration).
    Role: Principal Investigator

Featured Content

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Duffy SS, Keating BA, Perera CJ, Lees JG, Tonkin RS, Makker PGS, Carrive P, Butovsky O, Moalem-Taylor G. Regulatory T Cells and Their Derived Cytokine, Interleukin-35, Reduce Pain in Experimental Autoimmune Encephalomyelitis. J Neurosci. 2019 Mar 20; 39(12):2326-2346. PMID: 30651334.
    Citations:    Fields:    
  2. Faustino J, Chip S, Derugin N, Jullienne A, Hamer M, Haddad E, Butovsky O, Obenaus A, Vexler ZS. CX3CR1-CCR2-dependent monocyte-microglial signaling modulates neurovascular leakage and acute injury in a mouse model of childhood stroke. J Cereb Blood Flow Metab. 2019 Jan 10; 271678X18817663. PMID: 30628839.
    Citations:    Fields:    
  3. Parhizkar S, Arzberger T, Brendel M, Kleinberger G, Deussing M, Focke C, Nuscher B, Xiong M, Ghasemigharagoz A, Katzmarski N, Krasemann S, Lichtenthaler SF, Müller SA, Colombo A, Monasor LS, Tahirovic S, Herms J, Willem M, Pettkus N, Butovsky O, Bartenstein P, Edbauer D, Rominger A, Ertürk A, Grathwohl SA, Neher JJ, Holtzman DM, Meyer-Luehmann M, Haass C. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat Neurosci. 2019 Feb; 22(2):191-204. PMID: 30617257.
    Citations:    Fields:    
  4. Lund H, Pieber M, Parsa R, Han J, Grommisch D, Ewing E, Kular L, Needhamsen M, Espinosa A, Nilsson E, Överby AK, Butovsky O, Jagodic M, Zhang XM, Harris RA. Competitive repopulation of an empty microglial niche yields functionally distinct subsets of microglia-like cells. Nat Commun. 2018 11 19; 9(1):4845. PMID: 30451869.
    Citations:    Fields:    Translation:AnimalsCells
  5. Rubino SJ, Mayo L, Wimmer I, Siedler V, Brunner F, Hametner S, Madi A, Lanser A, Moreira T, Donnelly D, Cox L, Rezende RM, Butovsky O, Lassmann H, Weiner HL. Acute microglia ablation induces neurodegeneration in the somatosensory system. Nat Commun. 2018 Nov 01; 9(1):4578. PMID: 30385785.
    Citations:    Fields:    
  6. Butovsky O, Weiner HL. Microglial signatures and their role in health and disease. Nat Rev Neurosci. 2018 Oct; 19(10):622-635. PMID: 30206328.
    Citations:    Fields:    
  7. Okunuki Y, Mukai R, Pearsall EA, Klokman G, Husain D, Park DH, Korobkina E, Weiner HL, Butovsky O, Ksander BR, Miller JW, Connor KM. Microglia inhibit photoreceptor cell death and regulate immune cell infiltration in response to retinal detachment. Proc Natl Acad Sci U S A. 2018 07 03; 115(27):E6264-E6273. PMID: 29915052.
    Citations: 1     Fields:    Translation:AnimalsCells
  8. Zrzavy T, Höftberger R, Berger T, Rauschka H, Butovsky O, Weiner H, Lassmann H. Pro-inflammatory activation of microglia in the brain of patients with sepsis. Neuropathol Appl Neurobiol. 2018 May 27. PMID: 29804289.
    Citations:    Fields:    
  9. Calcagno N, Baufeld C, Madore C, Butovsky O. TREMendous 2 Be Social. Immunity. 2018 05 15; 48(5):842-843. PMID: 29768169.
    Citations:    Fields:    Translation:AnimalsCells
  10. Lund H, Pieber M, Parsa R, Grommisch D, Ewing E, Kular L, Han J, Zhu K, Nijssen J, Hedlund E, Needhamsen M, Ruhrmann S, Guerreiro-Cacais AO, Berglund R, Forteza MJ, Ketelhuth DFJ, Butovsky O, Jagodic M, Zhang XM, Harris RA. Fatal demyelinating disease is induced by monocyte-derived macrophages in the absence of TGF-ß signaling. Nat Immunol. 2018 May; 19(5):1-7. PMID: 29662171.
    Citations:    Fields:    
  11. O'Loughlin E, Madore C, Lassmann H, Butovsky O. Microglial Phenotypes and Functions in Multiple Sclerosis. Cold Spring Harb Perspect Med. 2018 02 01; 8(2). PMID: 29419406.
    Citations: 1     Fields:    
  12. Katsumoto A, Miranda AS, Butovsky O, Teixeira AL, Ransohoff RM, Lamb BT. Laquinimod attenuates inflammation by modulating macrophage functions in traumatic brain injury mouse model. J Neuroinflammation. 2018 Jan 30; 15(1):26. PMID: 29382353.
    Citations:    Fields:    
  13. Zrzavy T, Machado-Santos J, Christine S, Baumgartner C, Weiner HL, Butovsky O, Lassmann H. Dominant role of microglial and macrophage innate immune responses in human ischemic infarcts. Brain Pathol. 2018 11; 28(6):791-805. PMID: 29222823.
    Citations: 2     Fields:    
  14. Baufeld C, O'Loughlin E, Calcagno N, Madore C, Butovsky O. Differential contribution of microglia and monocytes in neurodegenerative diseases. J Neural Transm (Vienna). 2018 May; 125(5):809-826. PMID: 29063348.
    Citations: 3     Fields:    
  15. Shi Y, Yamada K, Liddelow SA, Smith ST, Zhao L, Luo W, Tsai RM, Spina S, Grinberg LT, Rojas JC, Gallardo G, Wang K, Roh J, Robinson G, Finn MB, Jiang H, Sullivan PM, Baufeld C, Wood MW, Sutphen C, McCue L, Xiong C, Del-Aguila JL, Morris JC, Cruchaga C, Fagan AM, Miller BL, Boxer AL, Seeley WW, Butovsky O, Barres BA, Paul SM, Holtzman DM. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature. 2017 09 28; 549(7673):523-527. PMID: 28959956.
    Citations: 34     Fields:    Translation:HumansAnimalsCells
  16. Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, Beckers L, O'Loughlin E, Xu Y, Fanek Z, Greco DJ, Smith ST, Tweet G, Humulock Z, Zrzavy T, Conde-Sanroman P, Gacias M, Weng Z, Chen H, Tjon E, Mazaheri F, Hartmann K, Madi A, Ulrich JD, Glatzel M, Worthmann A, Heeren J, Budnik B, Lemere C, Ikezu T, Heppner FL, Litvak V, Holtzman DM, Lassmann H, Weiner HL, Ochando J, Haass C, Butovsky O. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity. 2017 09 19; 47(3):566-581.e9. PMID: 28930663.
    Citations: 57     Fields:    Translation:HumansAnimalsCells
  17. Zrzavy T, Hametner S, Wimmer I, Butovsky O, Weiner HL, Lassmann H. Loss of 'homeostatic' microglia and patterns of their activation in active multiple sclerosis. Brain. 2017 Jul 01; 140(7):1900-1913. PMID: 28541408.
    Citations: 10     Fields:    Translation:HumansCells
  18. Madore C, Baufeld C, Butovsky O. Microglial confetti party. Nat Neurosci. 2017 May 25; 20(6):762-763. PMID: 28542157.
    Citations: 1     Fields:    
  19. Mazaheri F, Snaidero N, Kleinberger G, Madore C, Daria A, Werner G, Krasemann S, Capell A, Trümbach D, Wurst W, Brunner B, Bultmann S, Tahirovic S, Kerschensteiner M, Misgeld T, Butovsky O, Haass C. TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury. EMBO Rep. 2017 07; 18(7):1186-1198. PMID: 28483841.
    Citations: 16     Fields:    Translation:HumansCells
  20. Colonna M, Butovsky O. Microglia Function in the Central Nervous System During Health and Neurodegeneration. Annu Rev Immunol. 2017 04 26; 35:441-468. PMID: 28226226.
    Citations: 41     Fields:    Translation:HumansAnimalsCells
  21. Makker PG, Duffy SS, Lees JG, Perera CJ, Tonkin RS, Butovsky O, Park SB, Goldstein D, Moalem-Taylor G. Characterisation of Immune and Neuroinflammatory Changes Associated with Chemotherapy-Induced Peripheral Neuropathy. PLoS One. 2017; 12(1):e0170814. PMID: 28125674.
    Citations: 13     Fields:    Translation:AnimalsCells
  22. Drokhlyansky E, Göz Aytürk D, Soh TK, Chrenek R, O'Loughlin E, Madore C, Butovsky O, Cepko CL. The brain parenchyma has a type I interferon response that can limit virus spread. Proc Natl Acad Sci U S A. 2017 01 03; 114(1):E95-E104. PMID: 27980033.
    Citations: 6     Fields:    Translation:AnimalsCells
  23. Muth C, Schröck K, Madore C, Hartmann K, Fanek Z, Butovsky O, Glatzel M, Krasemann S. Activation of microglia by retroviral infection correlates with transient clearance of prions from the brain but does not change incubation time. Brain Pathol. 2017 Sep; 27(5):590-602. PMID: 27558169.
    Citations: 4     Fields:    Translation:AnimalsCells
  24. Delpech JC, Wei L, Hao J, Yu X, Madore C, Butovsky O, Kaffman A. Early life stress perturbs the maturation of microglia in the developing hippocampus. Brain Behav Immun. 2016 Oct; 57:79-93. PMID: 27301858.
    Citations: 9     Fields:    Translation:AnimalsCells
  25. Smith B, Whang J, Butovsky O, Scholz J. (272) Intraspinal chemokine signaling in the spared nerve injury model of neuropathic pain. J Pain. 2016 Apr; 17(4S):S44. PMID: 28162508.
    Citations:    
  26. Bisht K, Sharma KP, Lecours C, Sánchez MG, El Hajj H, Milior G, Olmos-Alonso A, Gómez-Nicola D, Luheshi G, Vallières L, Branchi I, Maggi L, Limatola C, Butovsky O, Tremblay MÈ. Dark microglia: A new phenotype predominantly associated with pathological states. Glia. 2016 May; 64(5):826-39. PMID: 26847266; PMCID: PMC4949554.
    Citations: 34     Fields:    Translation:AnimalsCells
  27. Butovsky O, Jedrychowski MP, Cialic R, Murugaiyan G, Wu PM, Doykan CE, Fanek Z, Greco DJ, Kiner O, Lawson RJ, Frosch MP, Pochet N, Krichevsky AM, Gygi SP, Berry J, Cudkowicz ME, Weiner HL. Targeting miR-155 restores dysfunctional microglia and ameliorates disease in the SOD1 model of ALS. Int J Dev Neurosci. 2015 Dec; 47(Pt A):5. PMID: 26531345.
    Citations:    
  28. Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, Koeglsperger T, Dake B, Wu PM, Doykan CE, Fanek Z, Liu L, Chen Z, Rothstein JD, Ransohoff RM, Gygi SP, Antel JP, Weiner HL. Identification of a unique molecular and functional microglia signature in health and disease. Int J Dev Neurosci. 2015 Dec; 47(Pt A):5. PMID: 26531346.
    Citations:    
  29. Butovsky O, Jedrychowski MP, Cialic R, Murugaiyan G, Wu PM, Doykan CE, Fanek Z, Greco DJ, Kiner O, Lawson RJ, Frosch MP, Pochet N, Krichevsky AM, Gygi SP, Berry J, Cudkowicz ME, Weiner HL. REMOVED: Targeting miR-155 restores dysfunctional microglia and ameliorates disease in the SOD1 model of ALS. Int J Dev Neurosci. 2015 Dec; 47(Pt A):5. PMID: 29887088.
    Citations:    Fields:    
  30. Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, Koeglsperger T, Dake B, Wu PM, Doykan CE, Fanek Z, Liu L, Chen Z, Rothstein JD, Ransohoff RM, Gygi SP, Antel JP, Weiner HL. REMOVED: Identification of a unique molecular and functional microglia signature in health and disease. Int J Dev Neurosci. 2015 Dec; 47(Pt A):5. PMID: 29887087.
    Citations:    Fields:    
  31. Asai H, Ikezu S, Tsunoda S, Medalla M, Luebke J, Haydar T, Wolozin B, Butovsky O, Kügler S, Ikezu T. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci. 2015 Nov; 18(11):1584-93. PMID: 26436904; PMCID: PMC4694577.
    Citations: 138     Fields:    Translation:AnimalsCells
  32. Verheijden S, Beckers L, Casazza A, Butovsky O, Mazzone M, Baes M. Identification of a chronic non-neurodegenerative microglia activation state in a mouse model of peroxisomal ß-oxidation deficiency. Glia. 2015 Sep; 63(9):1606-20. PMID: 25846981.
    Citations: 7     Fields:    Translation:AnimalsCells
  33. Moore CS, Ase AR, Kinsara A, Rao VT, Michell-Robinson M, Leong SY, Butovsky O, Ludwin SK, Séguéla P, Bar-Or A, Antel JP. P2Y12 expression and function in alternatively activated human microglia. Neurol Neuroimmunol Neuroinflamm. 2015 Apr; 2(2):e80. PMID: 25821842; PMCID: PMC4370387.
    Citations: 24     
  34. Jay TR, Miller CM, Cheng PJ, Graham LC, Bemiller S, Broihier ML, Xu G, Margevicius D, Karlo JC, Sousa GL, Cotleur AC, Butovsky O, Bekris L, Staugaitis SM, Leverenz JB, Pimplikar SW, Landreth GE, Howell GR, Ransohoff RM, Lamb BT. TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models. J Exp Med. 2015 Mar 09; 212(3):287-95. PMID: 25732305; PMCID: PMC4354365.
    Citations: 114     Fields:    Translation:HumansAnimalsCells
  35. Butovsky O, Jedrychowski MP, Cialic R, Krasemann S, Murugaiyan G, Fanek Z, Greco DJ, Wu PM, Doykan CE, Kiner O, Lawson RJ, Frosch MP, Pochet N, Fatimy RE, Krichevsky AM, Gygi SP, Lassmann H, Berry J, Cudkowicz ME, Weiner HL. Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice. Ann Neurol. 2015 Jan; 77(1):75-99. PMID: 25381879; PMCID: PMC4432483.
    Citations: 61     Fields:    Translation:HumansAnimalsCells
  36. Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, Koeglsperger T, Dake B, Wu PM, Doykan CE, Fanek Z, Liu L, Chen Z, Rothstein JD, Ransohoff RM, Gygi SP, Antel JP, Weiner HL. Corrigendum: Identification of a unique TGF-ß-dependent molecular and functional signature in microglia. Nat Neurosci. 2014 Aug 26; 17(9):1286. PMID: 25157514.
    Citations:    
  37. Yamasaki R, Lu H, Butovsky O, Ohno N, Rietsch AM, Cialic R, Wu PM, Doykan CE, Lin J, Cotleur AC, Kidd G, Zorlu MM, Sun N, Hu W, Liu L, Lee JC, Taylor SE, Uehlein L, Dixon D, Gu J, Floruta CM, Zhu M, Charo IF, Weiner HL, Ransohoff RM. Differential roles of microglia and monocytes in the inflamed central nervous system. J Exp Med. 2014 Jul 28; 211(8):1533-49. PMID: 25002752; PMCID: PMC4113947.
    Citations: 174     Fields:    Translation:HumansAnimalsCells
  38. Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, Koeglsperger T, Dake B, Wu PM, Doykan CE, Fanek Z, Liu L, Chen Z, Rothstein JD, Ransohoff RM, Gygi SP, Antel JP, Weiner HL. Identification of a unique TGF-ß-dependent molecular and functional signature in microglia. Nat Neurosci. 2014 Jan; 17(1):131-43. PMID: 24316888.
    Citations: 376     Fields:    Translation:HumansAnimalsCells
  39. Butovsky O, Siddiqui S, Gabriely G, Lanser AJ, Dake B, Murugaiyan G, Doykan CE, Wu PM, Gali RR, Iyer LK, Lawson R, Berry J, Krichevsky AM, Cudkowicz ME, Weiner HL. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J Clin Invest. 2012 Sep; 122(9):3063-87. PMID: 22863620; PMCID: PMC3428086.
    Citations: 138     Fields:    Translation:HumansAnimalsCells
  40. Vaknin I, Kunis G, Miller O, Butovsky O, Bukshpan S, Beers DR, Henkel JS, Yoles E, Appel SH, Schwartz M. Excess circulating alternatively activated myeloid (M2) cells accelerate ALS progression while inhibiting experimental autoimmune encephalomyelitis. PLoS One. 2011; 6(11):e26921. PMID: 22073221; PMCID: PMC3207825.
    Citations: 25     Fields:    Translation:Animals
  41. Landa G, Butovsky O, Shoshani J, Schwartz M, Pollack A. Weekly vaccination with Copaxone (glatiramer acetate) as a potential therapy for dry age-related macular degeneration. Curr Eye Res. 2008 Nov; 33(11):1011-3. PMID: 19085384.
    Citations: 10     Fields:    Translation:HumansPHPublic Health
  42. Butovsky O, Kunis G, Koronyo-Hamaoui M, Schwartz M. Selective ablation of bone marrow-derived dendritic cells increases amyloid plaques in a mouse Alzheimer's disease model. Eur J Neurosci. 2007 Jul; 26(2):413-6. PMID: 17623022.
    Citations: 51     Fields:    Translation:HumansAnimalsCells
  43. Butovsky O, Bukshpan S, Kunis G, Jung S, Schwartz M. Microglia can be induced by IFN-gamma or IL-4 to express neural or dendritic-like markers. Mol Cell Neurosci. 2007 Jul; 35(3):490-500. PMID: 17560122.
    Citations: 25     Fields:    Translation:AnimalsCells
  44. Butovsky O, Koronyo-Hamaoui M, Kunis G, Ophir E, Landa G, Cohen H, Schwartz M. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proc Natl Acad Sci U S A. 2006 Aug 01; 103(31):11784-9. PMID: 16864778; PMCID: PMC1544247.
    Citations: 98     Fields:    Translation:AnimalsCells
  45. Butovsky O, Landa G, Kunis G, Ziv Y, Avidan H, Greenberg N, Schwartz A, Smirnov I, Pollack A, Jung S, Schwartz M. Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. J Clin Invest. 2006 Apr; 116(4):905-15. PMID: 16557302; PMCID: PMC1409740.
    Citations: 78     Fields:    Translation:AnimalsCells
  46. Schwartz M, Butovsky O, Kipnis J. Does inflammation in an autoimmune disease differ from inflammation in neurodegenerative diseases? Possible implications for therapy. J Neuroimmune Pharmacol. 2006 Mar; 1(1):4-10. PMID: 18040786.
    Citations: 7     Fields:    Translation:HumansAnimalsCells
  47. Ziv Y, Ron N, Butovsky O, Landa G, Sudai E, Greenberg N, Cohen H, Kipnis J, Schwartz M. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat Neurosci. 2006 Feb; 9(2):268-75. PMID: 16415867.
    Citations: 301     Fields:    Translation:AnimalsCells
  48. Schwartz M, Butovsky O, Brück W, Hanisch UK. Microglial phenotype: is the commitment reversible? Trends Neurosci. 2006 Feb; 29(2):68-74. PMID: 16406093.
    Citations: 133     Fields:    Translation:HumansAnimalsCells
  49. Butovsky O, Ziv Y, Schwartz A, Landa G, Talpalar AE, Pluchino S, Martino G, Schwartz M. Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol Cell Neurosci. 2006 Jan; 31(1):149-60. PMID: 16297637.
    Citations: 262     Fields:    Translation:AnimalsCells
  50. Butovsky O, Talpalar AE, Ben-Yaakov K, Schwartz M. Activation of microglia by aggregated beta-amyloid or lipopolysaccharide impairs MHC-II expression and renders them cytotoxic whereas IFN-gamma and IL-4 render them protective. Mol Cell Neurosci. 2005 Jul; 29(3):381-93. PMID: 15890528.
    Citations: 86     Fields:    Translation:AnimalsCells
  51. Avidan H, Kipnis J, Butovsky O, Caspi RR, Schwartz M. Vaccination with autoantigen protects against aggregated beta-amyloid and glutamate toxicity by controlling microglia: effect of CD4+CD25+ T cells. Eur J Immunol. 2004 Dec; 34(12):3434-45. PMID: 15549735.
    Citations: 19     Fields:    Translation:AnimalsCellsPHPublic Health
  52. Ibarra A, Hauben E, Butovsky O, Schwartz M. The therapeutic window after spinal cord injury can accommodate T cell-based vaccination and methylprednisolone in rats. Eur J Neurosci. 2004 Jun; 19(11):2984-90. PMID: 15182305.
    Citations: 7     Fields:    Translation:AnimalsCells
  53. Hauben E, Gothilf A, Cohen A, Butovsky O, Nevo U, Smirnov I, Yoles E, Akselrod S, Schwartz M. Vaccination with dendritic cells pulsed with peptides of myelin basic protein promotes functional recovery from spinal cord injury. J Neurosci. 2003 Sep 24; 23(25):8808-19. PMID: 14507981.
    Citations: 15     Fields:    Translation:AnimalsCellsPHPublic Health
  54. Bomstein Y, Marder JB, Vitner K, Smirnov I, Lisaey G, Butovsky O, Fulga V, Yoles E. Features of skin-coincubated macrophages that promote recovery from spinal cord injury. J Neuroimmunol. 2003 Sep; 142(1-2):10-6. PMID: 14512160.
    Citations: 30     Fields:    Translation:AnimalsCells
  55. Butovsky O, Hauben E, Schwartz M. Morphological aspects of spinal cord autoimmune neuroprotection: colocalization of T cells with B7--2 (CD86) and prevention of cyst formation. FASEB J. 2001 Apr; 15(6):1065-7. PMID: 11292669.
    Citations: 29     Fields:    Translation:AnimalsCells
  56. Fisher J, Levkovitch-Verbin H, Schori H, Yoles E, Butovsky O, Kaye JF, Ben-Nun A, Schwartz M. Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies. J Neurosci. 2001 Jan 01; 21(1):136-42. PMID: 11150329.
    Citations: 29     Fields:    Translation:AnimalsCellsPHPublic Health
  57. Hauben E, Butovsky O, Nevo U, Yoles E, Moalem G, Agranov E, Mor F, Leibowitz-Amit R, Pevsner E, Akselrod S, Neeman M, Cohen IR, Schwartz M. Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J Neurosci. 2000 Sep 01; 20(17):6421-30. PMID: 10964948.
    Citations: 59     Fields:    Translation:AnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Butovsky's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (251)
Explore
_
Co-Authors (23)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH/NCATS Clinical and Translational Science Award (CTSA) program, grant number UL1TR001102, and through institutional support from Harvard University, Harvard Medical School, Harvard T.H. Chan School of Public Health, Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, Massachusetts General Hospital and the Dana Farber Cancer Institute.